NCT02200991 - Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine | Biotech Hunter

Enrollment

136

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

LIXISENATIDE AVE0010

Pharmaceutical form:solution Route of administration: subcutaneous

DRUG

Sitagliptin

Pharmaceutical form:tablet Route of administration: oral

DRUG

Insulin glargine HOE901

Pharmaceutical form:solution Route of administration: subcutaneous

Trial Locations (20)

Investigational Site Number 392-107, Atsugi-shi

Investigational Site Number 392-125, Chiyoda-ku

Investigational Site Number 392-121, Chuoh-ku

Investigational Site Number 392-102, Ichihara-shi

Investigational Site Number 392-103, Kawaguchi-shi

Investigational Site Number 392-114, Kitamoto-shi

Investigational Site Number 392-122, Kobe

Investigational Site Number 392-126, Kumamoto

Investigational Site Number 392-127, Kumamoto

Investigational Site Number 392-101, Kyoto

Investigational Site Number 392-106, Matsudo-shi

Investigational Site Number 392-124, Mitaka-shi

Investigational Site Number 392-108, Mito

Investigational Site Number 392-119, Nerima-ku

Investigational Site Number 392-117, Okayama

Investigational Site Number 392-111, Sagamihara-shi

Investigational Site Number 392-110, Sapporo

Investigational Site Number 392-116, Satsumasendai-shi

Investigational Site Number 392-105, Shizuoka

Investigational Site Number 392-118, Suita-shi